CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 3 of 15

Annals of the Rheumatic Diseases

Briefs 81–120 of 596 CurrentRheuma has covered from this journal, newest publication first

Latest from Annals of the Rheumatic Diseases

All coverage, newest first

  1. Ann Rheum Dis

    Global and high-income regional burden and healthcare costs of musculoskeletal diseases, 1990-2023

    Research articleAcross diseases

  2. Ann Rheum Dis

    Single-cell multiomics reveals activation of the STAT3–PIM1 axis in T-cell subsets in proteinase 3-ANCA–positive granulomatosis with polyangiitis

    Mechanistic studyVasculitis & PMR

  3. Ann Rheum Dis

    Progression from symptom onset to rheumatoid arthritis: is the trajectory similar in anticitrullinated protein antibody-positive and -negative disease? A comparative longitudinal study

    Cohort studyRA

  4. Ann Rheum Dis

    Effect of apremilast on whole-body magnetic resonance imaging of peripheral and axial inflammation in patients with psoriatic arthritis

    Secondary analysisSpondyloarthritis & PsA

  5. Ann Rheum Dis

    International expert consensus recommendations on standardised nomenclature of SSA/Ro (TROVE2/Ro60 and TRIM21/Ro52) autoantibodies in autoimmune diseases

    Guideline or statementSjögren's & overlap

  6. Ann Rheum Dis

    Anti-PAD4 antibodies link autoimmunity to PAD4 with CTL-associated rheumatoid arthritis

    Mechanistic studyRA

  7. Ann Rheum Dis

    Broad screening of inflammation-associated proteins identifies serum CCL19 as a novel biomarker of disease activity in IgG4-related disease

    Diagnostic or prognostic studyAutoinflammatory & rare

  8. Ann Rheum Dis

    Thresholds for efficacy outcomes in psoriatic arthritis vary according to baseline disease activity but not according to prior tumour necrosis factor inhibitor treatment

    Meta-analysisSpondyloarthritis & PsA

  9. Ann Rheum Dis

    Whole blood transcriptome profiling in patients treated with deucravacitinib and novel mechanistic insights into TYK2 inhibition in lupus: results from a post hoc analysis of the PAISLEY SLE phase 2 trial

    Secondary analysisLupus & APS

  10. Ann Rheum Dis

    Myeloid dendritic cell subsets characterise muscle in patients with inclusion body myositis and correlate with the IFN-γ pathway and effector T cell markers

    Mechanistic studyMyositis

  11. Ann Rheum Dis

    Impact of tofacitinib on growth in patients with juvenile idiopathic arthritis

    Secondary analysisPediatric

  12. Ann Rheum Dis

    Efficacy and safety of nerandomilast in patients with autoimmune disease-related progressive pulmonary fibrosis in the FIBRONEER-ILD trial

    Secondary analysisAcross diseases

  13. Ann Rheum Dis

    Dual dynamics of persistence and recruitment characterise the ACPA-expressing B cell response in rheumatoid arthritis

    Mechanistic studyRA

  14. Ann Rheum Dis

    Deep profiling of lupus nephritis kidneys reveals dynamic changes in myeloid cells associated with disease progression

    Mechanistic studyLupus & APS

  15. Ann Rheum Dis

    Reduced versus standard dosing of Janus kinase inhibitors in rheumatoid arthritis: a propensity score–matched real-world study accounting for poor prognostic factors

    Cohort studyRA

  16. Ann Rheum Dis

    EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis: 2025 update

    Guideline or statementOsteoarthritis

  17. Ann Rheum Dis

    A pathogenic gut lipoglycan drives systemic thromboinflammation in lupus nephritis

    Mechanistic studyLupus & APS

  18. Ann Rheum Dis

    Response of ultrasound-assessed synovitis to baricitinib, in monotherapy and combined with methotrexate, compared with etanercept in rheumatoid arthritis: a randomised, international, multicentre trial

    Randomized controlled trialRA

  19. Ann Rheum Dis

    Musculoskeletal ultrasound findings in people with asymptomatic hyperuricemia: baseline analysis from the Transitions in Gout Research (TIGER) study using the OMERACT gout ultrasound semiquantitative scoring system

    Cross-sectional studyGout & crystals

  20. Ann Rheum Dis

    Human hypofunctional NCF1 variant aggravates salivary gland immunopathology in Sjögren’s disease by promoting switched memory B-cell recruitment and long-lived plasma cell differentiation

    Mechanistic studySjögren's & overlap

  21. Ann Rheum Dis

    Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2025 update of the EULAR recommendations for the management of rheumatoid arthritis

    Research articleRA

  22. Ann Rheum Dis

    Efgartigimod in Sjögren’s disease: a phase 2, randomised, placebo-controlled, parallel-group, double-blinded, proof-of-concept study (RHO)

    Randomized controlled trialSjögren's & overlap

  23. Ann Rheum Dis

    Upadacitinib vs adalimumab in patients with rheumatoid arthritis and a prior inadequate response or intolerance to a tumour necrosis factor inhibitor: 12-week results from the randomised, double-blind, SELECT-SWITCH study

    Randomized controlled trialRA

  24. Ann Rheum Dis

    RA and PsA synovial tissue single-cell analysis demonstrates differential fibroblast populations with distinct phenotypes and functional capacities

    Mechanistic studyRA

  25. Ann Rheum Dis

    Psoriatic arthritis monocyte DNA methylomes bridge joint and skin inflammatory pathways across rheumatoid arthritis and psoriasis

    Mechanistic studySpondyloarthritis & PsA

  26. Ann Rheum Dis

    Differentiation of physiological from pathological bone erosions in rheumatoid arthritis: an 8-year HR-pQCT study of the second metacarpal head

    Case-control studyRA

  27. Ann Rheum Dis

    Oral glucocorticoid treatment for checkpoint inhibitor-associated inflammatory arthritis does not affect cancer progression-free survival: a RADIOS Registry study

    Cohort studyAcross diseases

  28. Ann Rheum Dis

    Safety of synthetic and biological DMARDs: a systematic literature review informing the 2025 update of the EULAR recommendations for the management of rheumatoid arthritis

    Cohort studyRA

  29. Ann Rheum Dis

    Peripheral blood UBA1 variant burden predicts poor outcomes in VEXAS syndrome: a nationwide prospective study

    Cohort studyAutoinflammatory & rare

  30. Ann Rheum Dis

    Frequency and characteristics of axial involvement in psoriatic arthritis: results from the International Multicentre AXIS Study

    Cross-sectional studySpondyloarthritis & PsA

  31. Ann Rheum Dis

    EULAR recommendations for the management of Behçet’s syndrome: 2025 update

    Guideline or statementVasculitis & PMR

  32. Ann Rheum Dis

    An immunometabolic signature of major depressive disorder in systemic lupus erythematosus

    Cross-sectional studyLupus & APS

  33. Ann Rheum Dis

    Neutrophil transcriptomics in SLE reveals intrinsic disease signatures, shared ex vivo adaptation, and transcriptional reset after CAR T-cell therapy

    Mechanistic studyLupus & APS

  34. Ann Rheum Dis

    Risk score for early mortality to stratify for intensive SSc therapy in the EUSTAR network: the RESIST score

    Diagnostic or prognostic studySystemic sclerosis

  35. Ann Rheum Dis

    An app-based nonpharmacological intervention improves patient-reported disease activity, functionality, and quality of life in patients with axial spondyloarthritis: a randomised controlled trial

    Randomized controlled trialSpondyloarthritis & PsA

  36. Ann Rheum Dis

    EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update

    Guideline or statementRA

  37. Ann Rheum Dis

    Risk of first and second primary keratinocyte cancers in relation to treatment of rheumatoid arthritis with JAKi, TNFi, and non-TNFi bDMARDs—a Swedish nationwide study

    Cohort studyRA

  38. Ann Rheum Dis

    Quantitative MRI tenosynovitis volume explains the association between tendon involvement and future development of clinical arthritis in anti-cyclic citrullinated peptide-positive at-risk individuals

    Cohort studyRA

  39. Ann Rheum Dis

    Hand-dominant joint involvement pattern associates with favourable, and polyarthritis with unfavourable, treatment response to both csDMARDs and bDMARDs in early rheumatoid arthritis: a combined analysis of NORD-STAR and BeSt trials

    Meta-analysisRA

  40. Ann Rheum Dis

    Prevalence and impact of suspected fibromyalgia on disease outcomes and treatment in axial spondyloarthritis: 10-year follow-up data from the DESIR cohort

    Cohort studySpondyloarthritis & PsA

All 596 Briefs in ExploreShowing Briefs 81–120 of 596, newest first